Cargando…
Immunotherapy for Pediatric Leukemia
Substantial progress has been made in the treatment of leukemia in childhood. Despite this, leukemia remains a leading cause of pediatric cancer-related mortality and the prognosis is guarded for individuals with relapsed or refractory disease. Standard therapies are associated with a wide array of...
Autores principales: | Shah, Nirali N., Dave, Hema, Wayne, Alan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696894/ https://www.ncbi.nlm.nih.gov/pubmed/23847759 http://dx.doi.org/10.3389/fonc.2013.00166 |
Ejemplares similares
-
Immunotherapy Associated Neurotoxicity in Pediatric Oncology
por: Shalabi, Haneen, et al.
Publicado: (2022) -
Bioinformatic Description of Immunotherapy Targets for Pediatric T-Cell Leukemia and the Impact of Normal Gene Sets Used for Comparison
por: Orentas, Rimas J., et al.
Publicado: (2014) -
Immunotherapy Targets in Pediatric Cancer
por: Orentas, Rimas J., et al.
Publicado: (2012) -
Immunotherapy in Acute Myeloid Leukemia: Where We Stand
por: Isidori, Alessandro, et al.
Publicado: (2021) -
Antibody Therapy for Pediatric Leukemia
por: Vedi, Aditi, et al.
Publicado: (2014)